Physician profile
Jerry E Watson
NPI 1174519896
$2,064.57
in general payments reported to CMS, 2019-2025
16 companies · $665 in 2025
The $665 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.74 · 2021: $16.10 · 2022: $183 · 2023: $439 · 2024: $748 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,851.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $391.54 | 2022-2025 | Watchman Flx, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $305.00 | 2022-2025 | |
| Amgen INC. | $187.91 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $186.86 | 2023-2025 | |
| Cvrx, INC. | $163.84 | 2021-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $142.12 | 2024-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $141.00 | 2023 | Diamondback Coronary |
| Recor Medical INC | $122.12 | 2025 | Paradise Ultrasound Renal Denervation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.18 | 2023-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $96.95 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals Lp | $78.34 | 2022-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.12 | 2023-2024 | Lifevest |
| Novo Nordisk INC | $23.80 | 2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $20.10 | 2024 | |
| Irhythm Technologies, INC. | $19.95 | 2024 | Zio Xt Patch |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.